Literature DB >> 8328499

Acetylcholine-induced coronary vasoconstriction in young, heavy smokers with normal coronary arteriographic findings.

A Nitenberg1, I Antony, J M Foult.   

Abstract

PURPOSE: Cigarette smoking is a major coronary risk factor. Acetylcholine dilates coronary arteries in normal subjects, but acetylcholine-induced coronary constriction has been reported in patients with normal coronary arteriographic findings and other risk factors for coronary artery disease. The purpose of the present study was to evaluate the epicardial coronary artery response to acetylcholine in young, heavy smokers. SUBJECTS AND METHODS: Responses to stepwise infusion of acetylcholine (10(-8)M, 10(-7)M, 10(-6)M, and 10(-5)M) into the left coronary artery were studied in five young, heavy smokers and in five age-matched nonsmokers. All subjects were normotensive and had normal left ventricular function and coronary arteriographic findings. Levels of serum cholesterol, triglycerides, and low-density lipoprotein levels were within normal ranges. Vessel dimensions were measured on four different segments in each subject, with quantitative digital-substracted arteriography.
RESULTS: In smokers, no change was produced at the 10(-8) M and 10(-7) M concentrations of acetylcholine, but progressive diameter reduction was observed at 10(-6) M and 10(-5) M acetylcholine (-26.6% +/- 13.6%, p < 0.001; -42.2% +/- 9.5%, p < 0.001, respectively). In nonsmokers, a progressive diameter dilation was produced from 10(-8) M to 10(-6) M acetylcholine (+5.3% +/- 3.6%, p < 0.001; +12.4% +/- 6.5%, p < 0.001; +15.9% +/- 6.9%, p < 0.001, respectively), and no change was observed at 10(-5) M acetylcholine. In the two groups, all segments dilated after infusion of intracoronary isosorbide dinitrate.
CONCLUSION: The abnormal coronary vasoconstriction induced by acetylcholine in young, heavy smokers with angiographically normal coronary arteries suggests an endothelial vasodilator dysfunction. This mechanism may contribute to the pathogenesis of coronary artery disease in cigarette smokers.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8328499     DOI: 10.1016/0002-9343(93)90234-g

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  11 in total

Review 1.  Role of the vascular endothelium in patients with angina pectoris or acute myocardial infarction with normal coronary arteries.

Authors:  J Sztajzel; F Mach; A Righetti
Journal:  Postgrad Med J       Date:  2000-01       Impact factor: 2.401

Review 2.  Exercise and the nitric oxide vasodilator system.

Authors:  Andrew Maiorana; Gerard O'Driscoll; Roger Taylor; Daniel Green
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

3.  Long-term cigarette smoking is associated with increased myocardial perfusion heterogeneity assessed by positron emission tomography.

Authors:  J G Meeder; P K Blanksma; E E van der Wall; R L Anthonio; A T Willemsen; J Pruim; W Vaalburg; K I Lie
Journal:  Eur J Nucl Med       Date:  1996-11

4.  Cigarette smoke and adverse health effects: An overview of research trends and future needs.

Authors:  Sibu P Saha; Deepak K Bhalla; Thomas F Whayne; Cg Gairola
Journal:  Int J Angiol       Date:  2007

5.  Influence of smoking status on progression of endothelial dysfunction. TREND Investigators. Trial on Reversing Endothelial Dysfunction.

Authors:  C J Pepine; J D Schlaifer; G B Mancini; B Pitt; B J O'Neill; H E Haber
Journal:  Clin Cardiol       Date:  1998-05       Impact factor: 2.882

Review 6.  [The role of endothelial function for ischemic manifestations of coronary atherosclerosis].

Authors:  M Britten; V Schächinger
Journal:  Herz       Date:  1998-03       Impact factor: 1.443

7.  [Prevention of coronary heart disease: smoking].

Authors:  T Heitzer; T Meinertz
Journal:  Z Kardiol       Date:  2005

Review 8.  New concepts regarding events that lead to myocardial infarction.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1995-08       Impact factor: 3.727

9.  L-2-Oxothiazolidine-4-carboxylic acid reverses endothelial dysfunction in patients with coronary artery disease.

Authors:  J A Vita; B Frei; M Holbrook; N Gokce; C Leaf; J F Keaney
Journal:  J Clin Invest       Date:  1998-03-15       Impact factor: 14.808

10.  Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein.

Authors:  Joshua A Beckman; James K Liao; Shauna Hurley; Leslie A Garrett; Daoshan Chui; Debi Mitra; Mark A Creager
Journal:  Circ Res       Date:  2004-06-03       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.